Walking Fish Therapeutics
Kent Thudium has worked in the scientific field for over 30 years. In 1987, they began their career as a Scientist I at Chiron Corporation. In 2001, they joined Medarex as a Scientist II and Bristol Myers Squibb as a Principal Research Scientist. At Bristol Myers Squibb, their role included immune-oncology research and development, adaptive immunology, early discovery, and life cycle management/MOA. Kent was later promoted to Senior Principal Scientist at Bristol Myers Squibb. In 2022, they joined Walking Fish Therapeutics, Inc. as a Senior Principal Scientist.
Kent Thudium obtained their Bachelor of Science in Biochemistry from the University of California, Berkeley.
This person is not in any offices
Walking Fish Therapeutics
Walking Fish has created a broad B cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production. As a leader in B cell engineering, Walking Fish has made critical advances in engineering technologies and has a deep understanding of B cell biology.